Alliance Global Partners Comments on Flora Growth Corp.’s Q4 2025 Earnings (NASDAQ:FLGC)

Flora Growth Corp. (NASDAQ:FLGC) – Equities researchers at Alliance Global Partners issued their Q4 2025 earnings per share (EPS) estimates for shares of Flora Growth in a research note issued on Thursday, August 15th. Alliance Global Partners analyst A. Grey forecasts that the company will post earnings per share of $0.05 for the quarter. Alliance Global Partners has a “Neutral” rating on the stock. The consensus estimate for Flora Growth’s current full-year earnings is ($0.30) per share.

Flora Growth (NASDAQ:FLGC) last released its quarterly earnings data on Tuesday, May 14th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.22) by ($0.06). Flora Growth had a negative net margin of 75.95% and a negative return on equity of 144.44%. The company had revenue of $18.03 million for the quarter, compared to the consensus estimate of $19.04 million.

Separately, Roth Mkm reissued a “buy” rating and set a $6.00 price target (down from $7.00) on shares of Flora Growth in a research note on Thursday, May 16th.

Flora Growth Stock Performance

FLGC remained flat at $0.92 during trading on Friday. 4,882 shares of the company traded hands, compared to its average volume of 394,682. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.65 and a current ratio of 1.13. The stock has a 50-day moving average price of $1.02 and a 200-day moving average price of $1.26. Flora Growth has a 52 week low of $0.63 and a 52 week high of $5.48.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Flora Growth stock. Renaissance Technologies LLC increased its position in shares of Flora Growth Corp. (NASDAQ:FLGC) by 105.6% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 159,595 shares of the company’s stock after buying an additional 81,982 shares during the period. Renaissance Technologies LLC owned about 1.19% of Flora Growth worth $163,000 at the end of the most recent quarter. Institutional investors own 36.01% of the company’s stock.

Flora Growth Company Profile

Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products.